Literature DB >> 29781987

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens.

Olivier Loudig1, Christina Liu2, Thomas Rohan3, Iddo Z Ben-Dov4.   

Abstract

-Archived, clinically classified formalin-fixed paraffin-embedded (FFPE) tissues can provide nucleic acids for retrospective molecular studies of cancer development. By using non-invasive or pre-malignant lesions from patients who later develop invasive disease, gene expression analyses may help identify early molecular alterations that predispose to cancer risk. It has been well described that nucleic acids recovered from FFPE tissues have undergone severe physical damage and chemical modifications, which make their analysis difficult and generally requires adapted assays. MicroRNAs (miRNAs), however, which represent a small class of RNA molecules spanning only up to ~18-24 nucleotides, have been shown to withstand long-term storage and have been successfully analyzed in FFPE samples. Here we present a 3' barcoded complementary DNA (cDNA) library preparation protocol specifically optimized for the analysis of small RNAs extracted from archived tissues, which was recently demonstrated to be robust and highly reproducible when using archived clinical specimens stored for up to 35 years. This library preparation is well adapted to the multiplex analysis of compromised/degraded material where RNA samples (up to 18) are ligated with individual 3' barcoded adapters and then pooled together for subsequent enzymatic and biochemical preparations prior to analysis. All purifications are performed by polyacrylamide gel electrophoresis (PAGE), which allows size-specific selections and enrichments of barcoded small RNA species. This cDNA library preparation is well adapted to minute RNA inputs, as a pilot polymerase chain reaction (PCR) allows determination of a specific amplification cycle to produce optimal amounts of material for next-generation sequencing (NGS). This approach was optimized for the use of degraded FFPE RNA from specimens archived for up to 35 years and provides highly reproducible NGS data.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29781987      PMCID: PMC6101110          DOI: 10.3791/57471

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  23 in total

1.  Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.

Authors:  Orsi Giricz; Paul A Reynolds; Andrew Ramnauth; Christina Liu; Tao Wang; Lesley Stead; Geoffrey Childs; Thomas Rohan; Nella Shapiro; Susan Fineberg; Paraic A Kenny; Olivier Loudig
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

Review 2.  Excavation of a buried treasure--DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues.

Authors:  R Klopfleisch; A T A Weiss; A D Gruber
Journal:  Histol Histopathol       Date:  2011-06       Impact factor: 2.303

3.  Robust global microRNA expression profiling using next-generation sequencing technologies.

Authors:  Shirley Tam; Richard de Borja; Ming-Sound Tsao; John D McPherson
Journal:  Lab Invest       Date:  2014-01-20       Impact factor: 5.662

Review 4.  Improved microRNA quantification in total RNA from clinical samples.

Authors:  Ditte Andreasen; Jacob U Fog; William Biggs; Jesper Salomon; Ina K Dahslveen; Adam Baker; Peter Mouritzen
Journal:  Methods       Date:  2010-04       Impact factor: 3.608

Review 5.  MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.

Authors:  William C S Cho
Journal:  Int J Biochem Cell Biol       Date:  2009-12-22       Impact factor: 5.085

Review 6.  MiRNAs and cancer.

Authors:  Rosa Visone; Carlo M Croce
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

Review 7.  Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies.

Authors:  Angela Hui; Christine How; Emma Ito; Fei-Fei Liu
Journal:  BMC Cancer       Date:  2011-11-30       Impact factor: 4.430

8.  Effective DNA/RNA co-extraction for analysis of microRNAs, mRNAs, and genomic DNA from formalin-fixed paraffin-embedded specimens.

Authors:  Adam Kotorashvili; Andrew Ramnauth; Christina Liu; Juan Lin; Kenny Ye; Ryung Kim; Rachel Hazan; Thomas Rohan; Susan Fineberg; Olivier Loudig
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

Review 9.  MicroRNA expression in formalin-fixed paraffin embedded tissue using real time quantitative PCR: the strengths and pitfalls.

Authors:  J R Dijkstra; L J M Mekenkamp; S Teerenstra; I De Krijger; I D Nagtegaal
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

10.  Multi-platform analysis of microRNA expression measurements in RNA from fresh frozen and FFPE tissues.

Authors:  Christopher P Kolbert; Rod M Feddersen; Fariborz Rakhshan; Diane E Grill; Gyorgy Simon; Sumit Middha; Jin Sung Jang; Vernadette Simon; Debra A Schultz; Michael Zschunke; Wilma Lingle; Jennifer M Carr; E Aubrey Thompson; Ann L Oberg; Bruce W Eckloff; Eric D Wieben; Peter Li; Ping Yang; Jin Jen
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  3 in total

1.  Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study.

Authors:  Thomas E Rohan; Mindy Ginsberg; Yihong Wang; Fergus J Couch; Heather S Feigelson; Robert T Greenlee; Stacey Honda; Azadeh Stark; Dhananjay Chitale; Tao Wang; Xiaonan Xue; Maja H Oktay; Joseph A Sparano; Olivier Loudig
Journal:  BMJ Open       Date:  2021-10-26       Impact factor: 2.692

Review 2.  Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility.

Authors:  Megan I Mitchell; Junfeng Ma; Claire L Carter; Olivier Loudig
Journal:  Cancers (Basel)       Date:  2022-07-10       Impact factor: 6.575

3.  MiRNA expression deregulation correlates with the Oncotype DX® DCIS score.

Authors:  Olivier Loudig; Megan I Mitchell; Iddo Z Ben-Dov; Christina Liu; Susan Fineberg
Journal:  Breast Cancer Res       Date:  2022-09-12       Impact factor: 8.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.